Stocks making big premarket moves: WBD, CDTX, AVDL and more

Pre-market trading saw significant M&A activity, with Cidara Therapeutics surging 103% on Merck's $9.2 billion acquisition and Avadel Pharmaceuticals rising 19% following a higher bid from Lundbeck, while Warner Bros. Discovery gained nearly 3% on acquisition interest reports. Conversely, Walmart fell 3% on CEO transition news, and Robinhood declined 5% amid broader tech sector rotation concerns. Applied Materials dropped 6% due to a modest outlook despite strong Q4, contributing to a wider sell-off in Big Tech stocks like Alphabet and Nvidia, driven by worries over AI spending sustainability. StubHub also slumped 19% after reporting a substantial Q3 net loss.

Analysis

The market is currently characterized by significant M&A activity and a notable rotation away from the technology sector. Cidara Therapeutics surged 103% following Merck's $9.2 billion cash acquisition, while Avadel Pharmaceuticals gained 19% after Lundbeck's higher bid, highlighting robust M&A premiums in healthcare. Warner Bros. Discovery also rose nearly 3% on reports of multiple potential acquisition bids, indicating strong interest in media assets.

Conversely, the technology sector experienced a broader sell-off driven by investor concerns over high valuations and the sustainability of AI spending. Robinhood fell 5% despite reporting a 34% increase in equity trading volume and a 22% rise in options trading volume, reflecting this sentiment shift. Applied Materials dropped 6% due to a lackluster outlook for next year, with its $6.85 billion revenue guidance barely exceeding analyst expectations, despite strong fiscal Q4 results.

Major tech firms including Alphabet, Meta, Nvidia, Intel, Palantir, and Tesla saw declines of 2-4%, reinforcing the cautious investor sentiment towards the sector. Additionally, Walmart declined 3% following the announcement of CEO Doug McMillon's departure, signaling potential leadership transition uncertainty. StubHub slumped 19% after reporting a substantial third-quarter net loss of $1.33 billion, attributed to a one-time stock-based compensation charge, and further impacted by the absence of forward guidance.

Key Decisions for Investors

• Investors should closely monitor M&A developments, particularly in the healthcare and media sectors, as current activity suggests significant premium potential for target companies.
• Re-evaluate technology sector exposure, focusing on companies with sustainable growth models and realistic valuations, given the prevailing concerns over high valuations and AI spending sustainability.
• Exercise caution and conduct thorough due diligence on companies facing leadership transitions or reporting significant one-time charges without clear forward guidance, as these factors can introduce increased volatility and uncertainty.